The Baker Institute is committed to scientific excellence and our 2022 Best of Baker Awards recognise outstanding research achievement based on scientific publications. They demonstrate areas where scientific discoveries are likely to have significant impact in health and medical research.
Our focus now is on translating this research to develop new drugs and devices, to inform policy, to develop best-practice prevention and treatment guidelines, and to facilitate education programs for healthcare professionals.
This is how our research is making a difference to the health of Australians, and people around the world.
- Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort (Basic Science)
- Exercise for the P\prevention of anthracycline-induced functional disability and cardiac dysfunction: the BReast cancer randomised EXercise InTervention (BREXIT) study (Clinical/Epidemiology)
- Phenotyping the hypertensive heart (Review)
- Retention of the NLRP3 inflammasome-primed neutrophils in the bone marrow is essential for myocardial infarction-induced granulopoiesis (Basic Science)
- Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study (Clinical/Epidemiology)
- Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease (Basic Science)
- Genetically personalised organ-specific metabolic models in health and disease (Basic Science)
- CSM-potential: mapping protein interactions and biological ligands in 3D space using geometric deep learning (Basic Science)
- An ultrasound-responsive theranostic cyclodextrin-loaded nanoparticle for multimodal imaging and therapy for atherosclerosis (Basic Science)
- Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data (Clinical/Epidemiology)
- Inherited thrombophilias are associated with a higher risk of COVID-19-associated venous thromboembolism: a prospective population-based cohort study (Clinical/Epidemiology)
- Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting (Clinical/Epidemiology)
- Nurse-provided lung and inferior vena cava assessment in patients with heart failure (Clinical/Epidemiology)